Scientists probe immune Molecule's role in stuffy nose disease
NCT ID NCT05672030
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a molecule called IL-5 affects different cells in the sinuses of people with nasal polyps and a related condition called aspirin-exacerbated respiratory disease. Researchers analyzed tissue samples from 30 participants to understand how IL-5 contributes to immune problems. The goal was to learn more about the disease, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPIRIN-EXACERBATED RESPIRATORY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an asthma drug shrink nasal polyps? a major trial seeks answers
- Can a single drug shrink nasal polyps and restore breathing?
- Nanoparticle steroid spray could transform recovery after sinus surgery
- Could a single biologic replace steroid sprays for nasal polyps?
- New biologics offer hope for severe nasal polyps sufferers
- New asthma drug may change how patients react to aspirin